4.6 Article

Severe Phenotype in Patients with Large Deletions of NF1

Journal

CANCERS
Volume 13, Issue 12, Pages -

Publisher

MDPI
DOI: 10.3390/cancers13122963

Keywords

neurofibromatosis type 1; NF1; NF1 deletion; genotype-phenotype correlation; neurofibromas; NFs; malignant peripheral nerve sheath tumors; MPNSTs; tumor predisposition; learning disabilities; dysmorphism; skeletal abnormalities; cardiovascular abnormalities

Categories

Funding

  1. Association Neurofibromatoses et Recklinghausen Fondation CAP NF
  2. Ligue Francaise Contre les Neurofibromatoses
  3. INSERM (Nf1GeneModif project)
  4. Ministere de l'Enseignement Superieur et de la Recherche

Ask authors/readers for more resources

NF1 gene deletion is identified in 5-10% of NF1 patients, leading to a more severe phenotype characterized by cognitive impairments and various organic abnormalities. This study provides new insights into the specific clinical features associated with NF1 gene deletions, contributing to better follow-up care for affected patients.
Simple Summary Neurofibromatosis type 1 (NF1) is a genetic disorder caused by pathogenic variants in the NF1 tumor suppressor gene. In 5-10% of NF1 patients, a large heterozygous deletion of the whole NF1 gene is identified, leading to the commonly called NF1 microdeletion syndrome. NF1-deleted patients were previously reported to develop a particularly severe form of the disease with frequent cognitive impairment and an increased risk of benign and malignant tumors. Here, we performed a comprehensive clinical assessment of the largest NF1-deleted cohort to date, including 126 NF1 patients with a deletion of the NF1 gene. This work provides new insights into the specific phenotype associated with NF1 deletions and may contribute to improve the follow-up care of NF1 patients. Complete deletion of the NF1 gene is identified in 5-10% of patients with neurofibromatosis type 1 (NF1). Several studies have previously described particularly severe forms of the disease in NF1 patients with deletion of the NF1 locus, but comprehensive descriptions of large cohorts are still missing to fully characterize this contiguous gene syndrome. NF1-deleted patients were enrolled and phenotypically characterized with a standardized questionnaire between 2005 and 2020 from a large French NF1 cohort. Statistical analyses for main NF1-associated symptoms were performed versus an NF1 reference population. A deletion of the NF1 gene was detected in 4% (139/3479) of molecularly confirmed NF1 index cases. The median age of the group at clinical investigations was 21 years old. A comprehensive clinical assessment showed that 93% (116/126) of NF1-deleted patients fulfilled the NIH criteria for NF1. More than half had cafe-au-lait spots, skinfold freckling, Lisch nodules, neurofibromas, neurological abnormalities, and cognitive impairment or learning disabilities. Comparison with previously described classic NF1 cohorts showed a significantly higher proportion of symptomatic spinal neurofibromas, dysmorphism, learning disabilities, malignancies, and skeletal and cardiovascular abnormalities in the NF1-deleted group. We described the largest NF1-deleted cohort to date and clarified the more severe phenotype observed in these patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available